Keyword: Promedior

News

Roche Boosts Fibrotic Diseases with Promedior

21.02.2020 - Swiss pharma giant Roche has closed its acquisition of US clinical-stage biotech Promedior. Roche snapped up the Lexington, Massachusetts-based firm for an upfront cash payment of...

News

Bristol-Myers to Buy Fibrosis Drug and its Developer

03.09.2015 - Bristol-Myers Squibb (BMS) will pay as much as $1.25 billion for the worldwide rights to a developing fibrosis drug as part of a deal that also gives it the right to buy the...